Whitebox Advisors LLC bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 250,000 shares of the company’s stock, valued at approximately $2,532,000.
A number of other hedge funds have also modified their holdings of the company. Rangeley Capital LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $101,000. Athos Capital Ltd acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth approximately $507,000. Kepos Capital LP purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at $709,000. Affinity Asset Advisors LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth $2,538,000. Finally, Ghisallo Capital Management LLC acquired a new position in shares of Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $4,558,000.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
Shares of NASDAQ OACCU opened at $10.44 on Thursday. The company’s 50 day moving average price is $10.30. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.99 and a 52-week high of $10.60.
Oaktree Acquisition Corp. III Life Sciences Profile
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Featured Stories
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- How to Use the MarketBeat Excel Dividend Calculator
- SoFi Reports Strong Q1 Results, Raises 2025 Full-Year Guidance
- 10 Best Airline Stocks to Buy
- 3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows
- 3 Tickers Leading a Meme Stock Revival
- AMD Stock Signals Strong Buy Ahead of Earnings
Want to see what other hedge funds are holding OACCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU – Free Report).
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.